BRPI0813670A2 - Compostos para tratamento - Google Patents
Compostos para tratamentoInfo
- Publication number
- BRPI0813670A2 BRPI0813670A2 BRPI0813670-0A2A BRPI0813670A BRPI0813670A2 BR PI0813670 A2 BRPI0813670 A2 BR PI0813670A2 BR PI0813670 A BRPI0813670 A BR PI0813670A BR PI0813670 A2 BRPI0813670 A2 BR PI0813670A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment compounds
- compounds
- treatment
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94500607P | 2007-06-19 | 2007-06-19 | |
| PCT/GB2008/002066 WO2008155533A2 (en) | 2007-06-19 | 2008-06-17 | Phenothiazine compounds for treating mild cognitive impairment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0813670A2 true BRPI0813670A2 (pt) | 2014-12-30 |
Family
ID=39943003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0813670-0A2A BRPI0813670A2 (pt) | 2007-06-19 | 2008-06-17 | Compostos para tratamento |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9211294B2 (enExample) |
| EP (1) | EP2167095B1 (enExample) |
| JP (1) | JP5725605B2 (enExample) |
| CN (1) | CN101820884B (enExample) |
| AU (1) | AU2008265045B2 (enExample) |
| BR (1) | BRPI0813670A2 (enExample) |
| CA (1) | CA2690746C (enExample) |
| DK (1) | DK2167095T3 (enExample) |
| ES (1) | ES2739546T3 (enExample) |
| HR (1) | HRP20191513T1 (enExample) |
| HU (1) | HUE045460T2 (enExample) |
| MY (1) | MY177001A (enExample) |
| PL (1) | PL2167095T3 (enExample) |
| PT (1) | PT2167095T (enExample) |
| SI (1) | SI2167095T1 (enExample) |
| WO (1) | WO2008155533A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602007008550D1 (de) | 2006-03-29 | 2010-09-30 | Wista Lab Ltd | 3,7-diamino-10h-phenothiazinsalze und ihre verwendung |
| US9149481B2 (en) * | 2007-10-03 | 2015-10-06 | Wista Laboratories Ltd. | Therapeutic use of diaminophenothiazines |
| CN102958525B (zh) | 2010-04-30 | 2017-05-24 | 普罗瑟塔抗病毒股份有限公司 | 抗病毒化合物 |
| AU2011358840B2 (en) * | 2011-02-11 | 2017-05-04 | TauRx Therapeutics Management Ltd | Phenothiazine diaminium salts and their use |
| WO2012145567A1 (en) | 2011-04-20 | 2012-10-26 | Prosetta Antiviral Inc. | Antiviral compounds |
| WO2014120907A1 (en) * | 2013-01-30 | 2014-08-07 | Ecolab Usa Inc. | Hydrogen sulfide scavengers |
| US10304006B2 (en) * | 2013-02-15 | 2019-05-28 | The Charles Stark Draper Laboratory, Inc. | Method for integrating and fusing heterogeneous data types to perform predictive analysis |
| WO2016133995A1 (en) | 2015-02-17 | 2016-08-25 | Arizona Board Of Regents On Behalf Of Arizona State University | Phenothiazine analogues as mitochondrial therapeutic agents |
| HRP20230628T1 (hr) * | 2016-07-25 | 2023-09-29 | Wista Laboratories Ltd. | Primjena i doziranje diaminofenotiazina |
| GB201614834D0 (en) * | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
| PT3826639T (pt) | 2018-07-26 | 2024-10-09 | Wista Lab Ltd | Dosagem otimizada de diaminofenotiazinas em populações |
| MY209608A (en) * | 2019-04-10 | 2025-07-24 | Genting Taurx Diagnostic Centre Sdn Bhd | Adaptive neurological testing method |
| GB201909454D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Enhancers |
| GB201909493D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Therapeutic interactions |
| GB201909506D0 (en) | 2019-07-02 | 2019-08-14 | Wista Lab Ltd | Synaptopathies |
| JP2025518248A (ja) | 2022-05-31 | 2025-06-12 | ウィスタ ラボラトリーズ リミテッド | メチルチオニニウム（ｍｔ）含有化合物を利用した神経変性障害の処置 |
| WO2024184146A1 (en) | 2023-03-03 | 2024-09-12 | Wista Laboratories Ltd. | Diaminophenothiazine for the treatment of microvascular brain disease disease |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9506197D0 (en) * | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
| GB0017060D0 (en) * | 2000-07-11 | 2000-08-30 | Hunter Fleming Ltd | Production, stabilisation and use of reduced forms of pharmaceutical compounds |
| GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| CN1791408A (zh) * | 2003-04-03 | 2006-06-21 | 普拉纳生物技术有限公司 | 神经系统疾病的治疗 |
| US7790881B2 (en) * | 2004-09-23 | 2010-09-07 | Wista Laboratories Ltd. | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) |
| EP1799662B1 (en) * | 2004-09-23 | 2013-04-17 | Wista Laboratories Ltd. | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
| WO2006091728A2 (en) * | 2005-02-24 | 2006-08-31 | The Trustees Of The University Of Pennsylvania | Microtubule stabilizing compounds and methods of their use |
| EP2853293B1 (en) * | 2006-03-29 | 2017-11-22 | WisTa Laboratories Ltd. | Thioninium compounds and their use |
| DE602007008550D1 (de) | 2006-03-29 | 2010-09-30 | Wista Lab Ltd | 3,7-diamino-10h-phenothiazinsalze und ihre verwendung |
| JP5654748B2 (ja) * | 2006-03-29 | 2015-01-14 | ウイスタ・ラボラトリーズ・リミテッドＷｉｓｔａ Ｌａｂｏｒａｔｏｒｉｅｓ Ｌｔｄ． | タンパク質凝集の阻害物質 |
| EP2457904B1 (en) * | 2006-07-11 | 2014-11-19 | Wista Laboratories Ltd. | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
-
2008
- 2008-06-17 WO PCT/GB2008/002066 patent/WO2008155533A2/en not_active Ceased
- 2008-06-17 AU AU2008265045A patent/AU2008265045B2/en active Active
- 2008-06-17 US US12/665,608 patent/US9211294B2/en active Active
- 2008-06-17 PT PT08762390T patent/PT2167095T/pt unknown
- 2008-06-17 EP EP08762390.6A patent/EP2167095B1/en active Active
- 2008-06-17 SI SI200832080T patent/SI2167095T1/sl unknown
- 2008-06-17 HU HUE08762390A patent/HUE045460T2/hu unknown
- 2008-06-17 PL PL08762390T patent/PL2167095T3/pl unknown
- 2008-06-17 JP JP2010512761A patent/JP5725605B2/ja active Active
- 2008-06-17 DK DK08762390.6T patent/DK2167095T3/da active
- 2008-06-17 MY MYPI20095255A patent/MY177001A/en unknown
- 2008-06-17 BR BRPI0813670-0A2A patent/BRPI0813670A2/pt not_active Application Discontinuation
- 2008-06-17 HR HRP20191513 patent/HRP20191513T1/hr unknown
- 2008-06-17 CA CA2690746A patent/CA2690746C/en active Active
- 2008-06-17 ES ES08762390T patent/ES2739546T3/es active Active
- 2008-06-17 CN CN2008801031955A patent/CN101820884B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008155533A2 (en) | 2008-12-24 |
| AU2008265045B2 (en) | 2014-02-27 |
| PL2167095T3 (pl) | 2019-11-29 |
| JP2010530403A (ja) | 2010-09-09 |
| DK2167095T3 (da) | 2019-07-29 |
| AU2008265045A1 (en) | 2008-12-24 |
| PT2167095T (pt) | 2019-08-06 |
| US9211294B2 (en) | 2015-12-15 |
| US20100184752A1 (en) | 2010-07-22 |
| CN101820884A (zh) | 2010-09-01 |
| CA2690746A1 (en) | 2008-12-24 |
| EP2167095B1 (en) | 2019-05-29 |
| SI2167095T1 (sl) | 2019-09-30 |
| CN101820884B (zh) | 2013-08-28 |
| HUE045460T2 (hu) | 2019-12-30 |
| MY177001A (en) | 2020-09-01 |
| EP2167095A2 (en) | 2010-03-31 |
| JP5725605B2 (ja) | 2015-05-27 |
| CA2690746C (en) | 2018-01-02 |
| ES2739546T3 (es) | 2020-01-31 |
| WO2008155533A3 (en) | 2009-02-19 |
| HRP20191513T1 (hr) | 2019-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0813670A2 (pt) | Compostos para tratamento | |
| BRPI0813500A2 (pt) | Compostos antivirais | |
| BRPI0821086A2 (pt) | Compostos inseticidas | |
| DK2185567T3 (da) | Substituerede bicyclolactam-forbindelser | |
| BRPI0815042A2 (pt) | Compostos de pirazol | |
| EP2131749A4 (en) | Surgical stapling apparatus | |
| BRPI0910282A2 (pt) | Composto oxadiazo-antraceno para o tratamento de diabetes | |
| DK2175851T3 (da) | Biofilmbehandling | |
| BRPI0811264A2 (pt) | Compostos | |
| BRPI0809996A2 (pt) | Compostos | |
| BRPI0922884A2 (pt) | compostos para tratamento de câncer | |
| BRPI0814424A2 (pt) | Compostos heterociclila | |
| DK2173831T3 (da) | Brøndbehandling | |
| DK2235041T3 (da) | Antimikrobielle forbindelser | |
| BRPI0815181A2 (pt) | Compostos | |
| BRPI0820410A2 (pt) | Lactans substituídos terapêuticos | |
| BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
| HRP20160577T1 (hr) | Liječenje osteoartritisa | |
| BRPI0814613A2 (pt) | Compostos | |
| PL3825306T3 (pl) | Związki morfinanu | |
| BRPI0918508A2 (pt) | orto-aminoanilidas para o tratamento de câncer | |
| BRPI0922216A2 (pt) | tratamento para glomerulonefrite | |
| BRPI0909764A2 (pt) | compostos terapêuticos | |
| BRPI0812105A2 (pt) | Neramexano para o tratamento de nistagmo | |
| BRPI0906879A2 (pt) | Compostos terapêuticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25G | Requested change of headquarter approved |
Owner name: WISTA LABORATORIES LTD. (SG) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |